Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer or Other Disease
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Roswell Park Cancer Institute
University of Maryland, Baltimore
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
Yale University
National Cancer Institute (NCI)
Fred Hutchinson Cancer Center